GP Helios

GP HELIOS BY GENEZA PHARMACEUTICALS

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
 - active substance: clenbuterol, yohimbine 6.4 mg;
 - auxiliary substances:

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Beta-2 Agonist, Bronchodilator.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 48-72 Hours
Routes of administration: intramuscular injection
Dosage forms: (Men): 3.4-12.16 mg/day; (Women): -
Acne: no
Water retention: no
High blood pressure: no
Hepatotoxicity: no
Aromatase: no
Decreased HPTA function (own testosterone production): none
Anabolic activity: Not a steroid
Androgenic activity: Not a steroid
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 6.4 mg / 1 mL in 10 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

Geneza Pharmaceuticals
Europe